Red Cedar Investment Management’s Pfizer PFE Stock Holding History

Red Cedar Investment Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-16,862	Closed	-$618K	–	84
2023 Q2	$618K	Sell	16,862 -32,124	-66%	-$1.25M	0.09%	82
2023 Q1	$2M	Buy	48,986 +15,959	+48%	+$689K	0.31%	46
2022 Q4	$1.69M	Buy	33,027 +3,608	+12%	+$173K	0.27%	41
2022 Q3	$1.29M	Hold	29,419	–	–	0.22%	45
2022 Q2	$1.54M	Hold	29,419	–	–	0.25%	37
2022 Q1	$1.52M	Sell	29,419 -7,652	-21%	-$397K	0.21%	42
2021 Q4	$2.19M	Buy	37,071 +12,898	+53%	+$639K	0.26%	40
2021 Q3	$1.04M	Buy	+24,173	New	+$1.07M	0.14%	56
2021 Q1	–	Sell	-22,947	Closed	-$845K	–	92
2020 Q4	$845K	Buy	+22,947	New	+$842K	0.13%	56

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Red Cedar Investment Management's PFE Position: Q3 2023 in Review

Red Cedar Investment Management sold out of Pfizer (PFE) in Q3 2023, closing a stake of 16,862 shares — an estimated $618K sold.

Red Cedar Investment Management first reported a position in PFE in Q4 2020 and held it in 9 quarters. The position peaked at $2.19M in Q4 2021. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

Red Cedar Investment Management reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
Red Cedar Investment Management sold 16,862 Pfizer shares in Q3 2023, an estimated $618K.
Red Cedar Investment Management first reported a position in Pfizer in Q4 2020 and held it in 9 quarters.
Red Cedar Investment Management's Pfizer position peaked at $2.19M in Q4 2021.
2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Red Cedar Investment Management's 13F filing for Q3 2023, filed 30 Oct 2023.